Powell, S K
Khan, N
Parker, C L
Samulski, R J
Matsushima, G
Gray, S J
McCown, T J
Article History
Received: 27 May 2016
Revised: 28 July 2016
Accepted: 1 August 2016
First Online: 15 September 2016
Competing interests
: SJG and TJM are inventors for a filed patent by UNC that includes the Olig001 capsid and is licensed to Asklepios Biopharmaceutical. They have received royalties from Asklepios Biopharmaceutical for this patent. RJS is a scientific co-founder of Asklepios Biopharmaceutical. The remaining authors declare no conflict of interest.